• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传和循环生物标志物数据可改善一般人群中胰腺癌的风险预测。

Genetic and Circulating Biomarker Data Improve Risk Prediction for Pancreatic Cancer in the General Population.

机构信息

Program in Genetic Epidemiology and Statistical Genetics, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.

Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.

出版信息

Cancer Epidemiol Biomarkers Prev. 2020 May;29(5):999-1008. doi: 10.1158/1055-9965.EPI-19-1389. Epub 2020 Apr 22.

DOI:10.1158/1055-9965.EPI-19-1389
PMID:32321713
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8020898/
Abstract

BACKGROUND

Pancreatic cancer is the third leading cause of cancer death in the United States, and 80% of patients present with advanced, incurable disease. Risk markers for pancreatic cancer have been characterized, but combined models are not used clinically to identify individuals at high risk for the disease.

METHODS

Within a nested case-control study of 500 pancreatic cancer cases diagnosed after blood collection and 1,091 matched controls enrolled in four U.S. prospective cohorts, we characterized absolute risk models that included clinical factors (e.g., body mass index, history of diabetes), germline genetic polymorphisms, and circulating biomarkers.

RESULTS

Model discrimination showed an area under ROC curve of 0.62 via cross-validation. Our final integrated model identified 3.7% of men and 2.6% of women who had at least 3 times greater than average risk in the ensuing 10 years. Individuals within the top risk percentile had a 4% risk of developing pancreatic cancer by age 80 years and 2% 10-year risk at age 70 years.

CONCLUSIONS

Risk models that include established clinical, genetic, and circulating factors improved disease discrimination over models using clinical factors alone.

IMPACT

Absolute risk models for pancreatic cancer may help identify individuals in the general population appropriate for disease interception.

摘要

背景

在美国,胰腺癌是导致死亡的第三大癌症原因,80%的患者就诊时已处于晚期、无法治愈的疾病状态。已经对胰腺癌的风险标志物进行了特征描述,但尚未将这些标志物联合应用于临床,以识别出患有该疾病风险较高的个体。

方法

在一项嵌套病例对照研究中,对采集血液后确诊的 500 例胰腺癌病例(病例组)和来自四个美国前瞻性队列的 1091 例匹配对照者(对照组)进行了分析,我们对包括临床因素(如体重指数、糖尿病史)、种系遗传多态性和循环生物标志物在内的绝对风险模型进行了特征描述。

结果

通过交叉验证,模型的判别显示 ROC 曲线下面积为 0.62。我们最终的综合模型确定了 3.7%的男性和 2.6%的女性在接下来的 10 年内具有至少 3 倍于平均风险的情况。处于最高风险百分位的个体在 80 岁时患胰腺癌的风险为 4%,在 70 岁时的 10 年风险为 2%。

结论

包含已确立的临床、遗传和循环因素的风险模型提高了疾病的判别能力,优于仅使用临床因素的模型。

影响

胰腺癌的绝对风险模型可能有助于识别出一般人群中适合进行疾病干预的个体。

相似文献

1
Genetic and Circulating Biomarker Data Improve Risk Prediction for Pancreatic Cancer in the General Population.遗传和循环生物标志物数据可改善一般人群中胰腺癌的风险预测。
Cancer Epidemiol Biomarkers Prev. 2020 May;29(5):999-1008. doi: 10.1158/1055-9965.EPI-19-1389. Epub 2020 Apr 22.
2
Pancreatic Cancer Risk Associated with Prediagnostic Plasma Levels of Leptin and Leptin Receptor Genetic Polymorphisms.与诊断前血浆瘦素水平及瘦素受体基因多态性相关的胰腺癌风险
Cancer Res. 2016 Dec 15;76(24):7160-7167. doi: 10.1158/0008-5472.CAN-16-1699. Epub 2016 Oct 25.
3
An absolute risk model to identify individuals at elevated risk for pancreatic cancer in the general population.一种用于在普通人群中识别胰腺癌高危个体的绝对风险模型。
PLoS One. 2013 Sep 13;8(9):e72311. doi: 10.1371/journal.pone.0072311. eCollection 2013.
4
Assessment of Lung Cancer Risk on the Basis of a Biomarker Panel of Circulating Proteins.基于循环蛋白生物标志物面板评估肺癌风险。
JAMA Oncol. 2018 Oct 1;4(10):e182078. doi: 10.1001/jamaoncol.2018.2078. Epub 2018 Oct 11.
5
A review of lifestyle, metabolic risk factors, and blood-based biomarkers for early diagnosis of pancreatic ductal adenocarcinoma.生活方式、代谢风险因素和基于血液的生物标志物在胰腺导管腺癌早期诊断中的研究进展。
J Gastroenterol Hepatol. 2019 Feb;34(2):330-345. doi: 10.1111/jgh.14576. Epub 2019 Jan 17.
6
A Predictive Noninvasive Single-Nucleotide Variation-Based Biomarker Signature for Resectable Pancreatic Cancer: Protocol for a Prospective Validation Study.基于预测性非侵入性单核苷酸变异的可切除胰腺癌生物标志物特征:一项前瞻性验证研究方案。
JMIR Res Protoc. 2024 May 13;13:e54042. doi: 10.2196/54042.
7
Predicting Pancreatic Cancer in New-Onset Diabetes Cohort Using a Novel Model With Integrated Clinical and Genetic Indicators: A Large-Scale Prospective Cohort Study.利用包含临床和遗传指标的新型模型预测新发糖尿病队列中的胰腺癌:一项大规模前瞻性队列研究。
Cancer Med. 2024 Nov;13(21):e70388. doi: 10.1002/cam4.70388.
8
Burden of hereditary cancer susceptibility in unselected patients with pancreatic ductal adenocarcinoma referred for germline screening.未选择的胰腺导管腺癌患者进行种系筛查的遗传性癌症易感性负担。
Cancer Med. 2020 Jun;9(11):4004-4013. doi: 10.1002/cam4.2973. Epub 2020 Apr 7.
9
Common genetic variants in prostate cancer risk prediction--results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3).常见的前列腺癌风险预测遗传变异——来自 NCI 乳腺癌和前列腺癌队列联盟(BPC3)的结果。
Cancer Epidemiol Biomarkers Prev. 2012 Mar;21(3):437-44. doi: 10.1158/1055-9965.EPI-11-1038. Epub 2012 Jan 11.
10
Inflammatory plasma markers and pancreatic cancer risk: a prospective study of five U.S. cohorts.炎性血浆标志物与胰腺癌风险:五项美国队列前瞻性研究。
Cancer Epidemiol Biomarkers Prev. 2013 May;22(5):855-61. doi: 10.1158/1055-9965.EPI-12-1458. Epub 2013 Mar 5.

引用本文的文献

1
Harnessing artificial intelligence for detection of pancreatic cancer: a machine learning approach.利用人工智能检测胰腺癌:一种机器学习方法。
Clin Exp Med. 2025 Jul 1;25(1):228. doi: 10.1007/s10238-025-01761-5.
2
An Integrative Pancreatic Cancer Risk Prediction Model in the UK Biobank.英国生物银行中的综合胰腺癌风险预测模型。
Biomedicines. 2023 Dec 1;11(12):3206. doi: 10.3390/biomedicines11123206.
3
A pancreatic cancer risk prediction model (Prism) developed and validated on large-scale US clinical data.基于大规模美国临床数据开发和验证的胰腺癌风险预测模型(Prism)。
EBioMedicine. 2023 Dec;98:104888. doi: 10.1016/j.ebiom.2023.104888. Epub 2023 Nov 25.
4
Diagnostic ability of deep learning in detection of pancreatic tumour.深度学习在胰腺肿瘤检测中的诊断能力。
Sci Rep. 2023 Jun 15;13(1):9725. doi: 10.1038/s41598-023-36886-8.
5
A deep learning algorithm to predict risk of pancreatic cancer from disease trajectories.一种基于深度学习算法的胰腺癌风险预测方法。
Nat Med. 2023 May;29(5):1113-1122. doi: 10.1038/s41591-023-02332-5. Epub 2023 May 8.
6
Germline Aberrations in Pancreatic Cancer: Implications for Clinical Care.胰腺癌中的种系畸变:对临床护理的影响。
Cancers (Basel). 2022 Jun 30;14(13):3239. doi: 10.3390/cancers14133239.
7
Current status of inherited pancreatic cancer.遗传性胰腺癌的现状
Hered Cancer Clin Pract. 2022 Jun 27;20(1):26. doi: 10.1186/s13053-022-00224-2.
8
The age-dependent association of risk factors with pancreatic cancer.年龄相关因素与胰腺癌的相关性。
Ann Oncol. 2022 Jul;33(7):693-701. doi: 10.1016/j.annonc.2022.03.276. Epub 2022 Apr 6.
9
Hepatocellular Carcinoma Risk Prediction in the NIH-AARP Diet and Health Study Cohort: A Machine Learning Approach.美国国立卫生研究院-美国退休人员协会饮食与健康研究队列中肝细胞癌风险预测:一种机器学习方法
J Hepatocell Carcinoma. 2022 Feb 15;9:69-81. doi: 10.2147/JHC.S341045. eCollection 2022.
10
Identification of Recessively Inherited Genetic Variants Potentially Linked to Pancreatic Cancer Risk.鉴定可能与胰腺癌风险相关的隐性遗传变异
Front Oncol. 2021 Dec 3;11:771312. doi: 10.3389/fonc.2021.771312. eCollection 2021.

本文引用的文献

1
Screening for Pancreatic Cancer: US Preventive Services Task Force Reaffirmation Recommendation Statement.筛查胰腺癌:美国预防服务工作组重新确认推荐声明。
JAMA. 2019 Aug 6;322(5):438-444. doi: 10.1001/jama.2019.10232.
2
Screening for Pancreatic Cancer.胰腺癌筛查
JAMA. 2019 Aug 6;322(5):407-408. doi: 10.1001/jama.2019.9690.
3
Circulating Leptin and Branched Chain Amino Acids-Correlation with Intraductal Papillary Mucinous Neoplasm Dysplastic Grade.循环瘦素与分支链氨基酸——与导管内乳头状黏液性肿瘤异型增生程度的相关性。
J Gastrointest Surg. 2019 May;23(5):966-974. doi: 10.1007/s11605-018-3963-y. Epub 2018 Sep 13.
4
A Plasma-Derived Protein-Metabolite Multiplexed Panel for Early-Stage Pancreatic Cancer.用于早期胰腺癌的血浆衍生蛋白代谢物多重分析面板。
J Natl Cancer Inst. 2019 Apr 1;111(4):372-379. doi: 10.1093/jnci/djy126.
5
A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarcinoma.一种可见且可量化的 CT 成像特征可识别胰腺导管腺癌的生物物理亚型。
Clin Cancer Res. 2018 Dec 1;24(23):5883-5894. doi: 10.1158/1078-0432.CCR-17-3668. Epub 2018 Aug 6.
6
Increased Levels of Branched-Chain Amino Acid Associated With Increased Risk of Pancreatic Cancer in a Prospective Case-Control Study of a Large Cohort.在一项针对大型队列的前瞻性病例对照研究中,支链氨基酸水平升高与胰腺癌风险增加相关。
Gastroenterology. 2018 Nov;155(5):1474-1482.e1. doi: 10.1053/j.gastro.2018.07.033. Epub 2018 Aug 1.
7
Systematic literature review of IL-6 as a biomarker or treatment target in patients with gastric, bile duct, pancreatic and colorectal cancer.白细胞介素-6作为胃癌、胆管癌、胰腺癌和结直肠癌患者生物标志物或治疗靶点的系统文献综述。
Oncotarget. 2018 Jul 3;9(51):29820-29841. doi: 10.18632/oncotarget.25661.
8
Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected pancreatic cancer.切除胰腺癌患者的种系癌症易感性基因变异、体细胞二次打击和生存结局。
Genet Med. 2019 Jan;21(1):213-223. doi: 10.1038/s41436-018-0009-5. Epub 2018 Jul 2.
9
Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic Cancer.遗传性癌症易感基因种系突变与胰腺癌风险的关联。
JAMA. 2018 Jun 19;319(23):2401-2409. doi: 10.1001/jama.2018.6228.
10
Model to Determine Risk of Pancreatic Cancer in Patients With New-Onset Diabetes.用于确定新发糖尿病患者罹患胰腺癌风险的模型。
Gastroenterology. 2018 Sep;155(3):730-739.e3. doi: 10.1053/j.gastro.2018.05.023. Epub 2018 Jun 11.